These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 12423799)

  • 21. Membrane lipids determine the antibiotic activity of the lantibiotic gallidermin.
    Christ K; Al-Kaddah S; Wiedemann I; Rattay B; Sahl HG; Bendas G
    J Membr Biol; 2008; 226(1-3):9-16. PubMed ID: 19009315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maturation pathway of nisin and other lantibiotics: post-translationally modified antimicrobial peptides exported by gram-positive bacteria.
    de Vos WM; Kuipers OP; van der Meer JR; Siezen RJ
    Mol Microbiol; 1995 Aug; 17(3):427-37. PubMed ID: 8559062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NisC binds the FxLx motif of the nisin leader peptide.
    Abts A; Montalban-Lopez M; Kuipers OP; Smits SH; Schmitt L
    Biochemistry; 2013 Aug; 52(32):5387-95. PubMed ID: 23869662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental and dynamic effects explain how nisin captures membrane-bound lipid II.
    Panina I; Krylov N; Nolde D; Efremov R; Chugunov A
    Sci Rep; 2020 Jun; 10(1):8821. PubMed ID: 32483218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic action of pediocin and nisin: recent progress and unresolved questions.
    Montville TJ; Chen Y
    Appl Microbiol Biotechnol; 1998 Nov; 50(5):511-9. PubMed ID: 9917136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of lipid II in membrane binding of and pore formation by nisin analyzed by two combined biosensor techniques.
    Christ K; Wiedemann I; Bakowsky U; Sahl HG; Bendas G
    Biochim Biophys Acta; 2007 Mar; 1768(3):694-704. PubMed ID: 17254547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Ca(2+) ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif.
    Böttiger T; Schneider T; Martínez B; Sahl HG; Wiedemann I
    Appl Environ Microbiol; 2009 Jul; 75(13):4427-34. PubMed ID: 19429551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of antibiotic mechanisms in lantibiotics.
    Hoffmann A; Pag U; Wiedemann I; Sahl HG
    Farmaco; 2002 Aug; 57(8):685-91. PubMed ID: 12361237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II.
    Wiedemann I; Böttiger T; Bonelli RR; Wiese A; Hagge SO; Gutsmann T; Seydel U; Deegan L; Hill C; Ross P; Sahl HG
    Mol Microbiol; 2006 Jul; 61(2):285-96. PubMed ID: 16771847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual mode of action of amylolysin: a type-B lantibiotic produced by Bacillus amyloliquefaciens GA1.
    Arguelles Arias A; Joris B; Fickers P
    Protein Pept Lett; 2014 Apr; 21(4):336-40. PubMed ID: 24164268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate analogues to study cell-wall biosynthesis and its inhibition.
    Lazar K; Walker S
    Curr Opin Chem Biol; 2002 Dec; 6(6):786-93. PubMed ID: 12470732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class II one-peptide bacteriocins target a phylogenetically defined subgroup of mannose phosphotransferase systems on sensitive cells.
    Kjos M; Nes IF; Diep DB
    Microbiology (Reading); 2009 Sep; 155(Pt 9):2949-2961. PubMed ID: 19477899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hit 'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II.
    Oppedijk SF; Martin NI; Breukink E
    Biochim Biophys Acta; 2016 May; 1858(5):947-57. PubMed ID: 26523408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Basis of the Mechanisms of Action and Immunity of Lactococcin A, a Class IId Bacteriocin.
    Li R; Duan J; Zhou Y; Wang J
    Appl Environ Microbiol; 2023 Mar; 89(3):e0006623. PubMed ID: 36840592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-encoded antibiotics made in bacteria.
    Sahl HG
    Ciba Found Symp; 1994; 186():27-42; discussion 42-53. PubMed ID: 7768156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A lesson in efficient killing from two-component lantibiotics.
    Breukink E
    Mol Microbiol; 2006 Jul; 61(2):271-3. PubMed ID: 16771845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The two-peptide class II bacteriocins: structure, production, and mode of action.
    Oppegård C; Rogne P; Emanuelsen L; Kristiansen PE; Fimland G; Nissen-Meyer J
    J Mol Microbiol Biotechnol; 2007; 13(4):210-9. PubMed ID: 17827971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides.
    Münch D; Sahl HG
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3062-71. PubMed ID: 25934055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of colicin M and its orthologs targeting bacterial cell wall peptidoglycan biosynthesis.
    Barreteau H; El Ghachi M; Barnéoud-Arnoulet A; Sacco E; Touzé T; Duché D; Gérard F; Brooks M; Patin D; Bouhss A; Blanot D; van Tilbeurgh H; Arthur M; Lloubès R; Mengin-Lecreulx D
    Microb Drug Resist; 2012 Jun; 18(3):222-9. PubMed ID: 22432709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane.
    Wenzel M; Kohl B; Münch D; Raatschen N; Albada HB; Hamoen L; Metzler-Nolte N; Sahl HG; Bandow JE
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5749-57. PubMed ID: 22926563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.